MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5 Drug Patent Profile
✉ Email this page to a colleague
When do Multiple Electrolytes Injection Type 1 Usp Ph 5.5 patents expire, and what generic alternatives are available?
Multiple Electrolytes Injection Type 1 Usp Ph 5.5 is a drug marketed by Fresenius Kabi Usa and is included in one NDA.
The generic ingredient in MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5 is magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate. There are one hundred and forty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate profile page.
Summary for MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 440 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5 at DailyMed |
Recent Clinical Trials for MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ain Shams University | Phase 3 |
Arab Contractors Medical Centre | Phase 4 |
Klinikum Nürnberg | Phase 2 |
See all MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5 clinical trials
Pharmacology for MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
Anatomical Therapeutic Chemical (ATC) Classes for MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
US Patents and Regulatory Information for MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 5.5 | magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium gluconate | INJECTABLE;INJECTION | 215370-001 | Jun 29, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |